Congenital Heart Disease Market Report

Global and Region Congenital Heart Disease Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：195
  • REPORT CODE：GMM926940
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Congenital Heart Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Congenital Heart Diseasemarket, defines the market attractiveness level of Congenital Heart Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Congenital Heart Disease industry, describes the types of Congenital Heart Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Congenital Heart Disease market and the development prospects and opportunities of Congenital Heart Disease industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Congenital Heart Disease market in Chapter 13.

    By Player:

    • AstraZeneca

    • Janssen Pharmaceuticals

    • Becton Dickinson

    • Medtronic

    • GSK

    • Mylan

    • Bio-Rad

    • Critical Diagnostics

    • Array BioPharma

    • Merck

    • Abbott Diagnostics

    • Covance

    • Roche

    • BG Medicine

    • Boston Scientific

    By Type:

    • Medications

    • Implantable heart devices

    • Catheter procedures

    • Open-heart surgery

    • Heart transplant

    By End-User:

    • Hospitals and clinics

    • Diagnostic centres

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Congenital Heart Disease Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Congenital Heart Disease Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Congenital Heart Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Congenital Heart Disease Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Congenital Heart Disease Market Analysis and Outlook to 2022

    • 7.1 Global Congenital Heart Disease Consumption (2017-2022)

    • 7.2 United States Congenital Heart Disease Consumption (2017-2022)

    • 7.3 Europe Congenital Heart Disease Consumption (2017-2022)

    • 7.4 China Congenital Heart Disease Consumption (2017-2022)

    • 7.5 Japan Congenital Heart Disease Consumption (2017-2022)

    • 7.6 India Congenital Heart Disease Consumption (2017-2022)

    • 7.7 South Korea Congenital Heart Disease Consumption (2017-2022)

    8 Region and Country-wise Congenital Heart Disease Market Analysis and Outlook to 2028

    • 8.1 Global Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.2 United States Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.3 Europe Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.4 China Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.5 Japan Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.6 India Congenital Heart Disease Consumption Forecast (2022-2028)

    • 8.7 South Korea Congenital Heart Disease Consumption Forecast (2022-2028)

    9 Global Congenital Heart Disease Market Outlook by Types and Applications to 2022

    • 9.1 Global Congenital Heart Disease Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Medications Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Implantable heart devices Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Catheter procedures Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Open-heart surgery Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Heart transplant Consumption and Growth Rate (2017-2022)

    • 9.2 Global Congenital Heart Disease Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic centres Consumption and Growth Rate (2017-2022)

    10 Global Congenital Heart Disease Market Outlook by Types and Applications to 2028

    • 10.1 Global Congenital Heart Disease Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Medications Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Implantable heart devices Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Catheter procedures Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Open-heart surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Heart transplant Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Congenital Heart Disease Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic centres Consumption Forecast and Growth Rate (2022-2028)

    11 Global Congenital Heart Disease Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Congenital Heart Disease Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Congenital Heart Disease Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Congenital Heart Disease Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Congenital Heart Disease Market Competitive Analysis

    • 14.1 AstraZeneca

      • 14.1.1 AstraZeneca Company Details

      • 14.1.2 AstraZeneca Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca Congenital Heart Disease Product and Service

    • 14.2 Janssen Pharmaceuticals

      • 14.2.1 Janssen Pharmaceuticals Company Details

      • 14.2.2 Janssen Pharmaceuticals Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Janssen Pharmaceuticals Congenital Heart Disease Product and Service

    • 14.3 Becton Dickinson

      • 14.3.1 Becton Dickinson Company Details

      • 14.3.2 Becton Dickinson Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Becton Dickinson Congenital Heart Disease Product and Service

    • 14.4 Medtronic

      • 14.4.1 Medtronic Company Details

      • 14.4.2 Medtronic Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Medtronic Congenital Heart Disease Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Congenital Heart Disease Product and Service

    • 14.6 Mylan

      • 14.6.1 Mylan Company Details

      • 14.6.2 Mylan Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mylan Congenital Heart Disease Product and Service

    • 14.7 Bio-Rad

      • 14.7.1 Bio-Rad Company Details

      • 14.7.2 Bio-Rad Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bio-Rad Congenital Heart Disease Product and Service

    • 14.8 Critical Diagnostics

      • 14.8.1 Critical Diagnostics Company Details

      • 14.8.2 Critical Diagnostics Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Critical Diagnostics Congenital Heart Disease Product and Service

    • 14.9 Array BioPharma

      • 14.9.1 Array BioPharma Company Details

      • 14.9.2 Array BioPharma Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Array BioPharma Congenital Heart Disease Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Congenital Heart Disease Product and Service

    • 14.11 Abbott Diagnostics

      • 14.11.1 Abbott Diagnostics Company Details

      • 14.11.2 Abbott Diagnostics Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Abbott Diagnostics Congenital Heart Disease Product and Service

    • 14.12 Covance

      • 14.12.1 Covance Company Details

      • 14.12.2 Covance Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Covance Congenital Heart Disease Product and Service

    • 14.13 Roche

      • 14.13.1 Roche Company Details

      • 14.13.2 Roche Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Roche Congenital Heart Disease Product and Service

    • 14.14 BG Medicine

      • 14.14.1 BG Medicine Company Details

      • 14.14.2 BG Medicine Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 BG Medicine Congenital Heart Disease Product and Service

    • 14.15 Boston Scientific

      • 14.15.1 Boston Scientific Company Details

      • 14.15.2 Boston Scientific Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Boston Scientific Congenital Heart Disease Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Congenital Heart Disease

    • Figure Congenital Heart Disease Picture

    • Table Global Congenital Heart Disease Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Congenital Heart Disease Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Congenital Heart Disease Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Congenital Heart Disease Consumption by Country (2017-2022)

    • Figure United States Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Table Europe Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure China Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Japan Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure India Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure South Korea Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Congenital Heart Disease Consumption Forecast by Country (2022-2028)

    • Figure United States Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medications Consumption and Growth Rate (2017-2022)

    • Figure Global Implantable heart devices Consumption and Growth Rate (2017-2022)

    • Figure Global Catheter procedures Consumption and Growth Rate (2017-2022)

    • Figure Global Open-heart surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Heart transplant Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic centres Consumption and Growth Rate (2017-2022)

    • Figure Global Medications Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Implantable heart devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Catheter procedures Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Open-heart surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart transplant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic centres Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Congenital Heart Disease Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Congenital Heart Disease Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Congenital Heart Disease Product and Service

    • Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Congenital Heart Disease Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Congenital Heart Disease Product and Service

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Congenital Heart Disease Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Congenital Heart Disease Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Congenital Heart Disease Product and Service

    • Table Bio-Rad (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Congenital Heart Disease Product and Service

    • Table Critical Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Critical Diagnostics Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Critical Diagnostics Congenital Heart Disease Product and Service

    • Table Array BioPharma (Foundation Year, Company Profile and etc.)

    • Table Array BioPharma Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Array BioPharma Congenital Heart Disease Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Congenital Heart Disease Product and Service

    • Table Abbott Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Abbott Diagnostics Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Diagnostics Congenital Heart Disease Product and Service

    • Table Covance (Foundation Year, Company Profile and etc.)

    • Table Covance Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covance Congenital Heart Disease Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Congenital Heart Disease Product and Service

    • Table BG Medicine (Foundation Year, Company Profile and etc.)

    • Table BG Medicine Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table BG Medicine Congenital Heart Disease Product and Service

    • Table Boston Scientific (Foundation Year, Company Profile and etc.)

    • Table Boston Scientific Congenital Heart Disease Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Congenital Heart Disease Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US